Page last updated: 2024-08-21

perfluorooctane and Eye Disorders

perfluorooctane has been researched along with Eye Disorders in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrés-Iglesias, C; Coco, RM; Dueñas, A; Fernandez-Bueno, I; García-Serna, J; Medina, J; Pastor, JC; Rull, F; Srivastava, GK1
Dresp, J; Feltgen, N; Hoerauf, H; Lechner, T; Menz, DH; Menz, H; Mueller, BK1
Diamint, DV; Pozzoni, MC; Ugradar, S1
Bourke, RD; Cooling, RJ; Simpson, RN; Sparrow, JR1
Meffert, S; Peyman, GA1
Arpa, P; Bottoni, F; De Molfetta, V; Vinciguerra, P; Zenoni, S1
Carter, JB; Glaser, BM; Kuppermann, BD; Michels, RG1

Trials

1 trial(s) available for perfluorooctane and Eye Disorders

ArticleYear
Intraoperative complications of perfluoroperhydrophenanthrene: subretinal perfluorocarbon, retinal slippage and residual perfluorocarbon. Vitreon Study Group.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1999, Volume: 34, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Eye Diseases; Female; Fluorocarbons; Humans; Incidence; Intraoperative Complications; Male; Middle Aged; Prospective Studies; Retinal Diseases; Safety; Vitreous Body

1999

Other Studies

6 other study(ies) available for perfluorooctane and Eye Disorders

ArticleYear
Chemical Considerations Regarding the H-Value Methodology and Its Relation With Toxicity Determination.
    Investigative ophthalmology & visual science, 2019, 08-01, Volume: 60, Issue:10

    Topics: Eye Diseases; Fluorocarbons; Humans

2019
Author Response: Chemical Considerations Regarding the H-Value Methodology and Its Relation With Toxicity Determination.
    Investigative ophthalmology & visual science, 2019, 08-01, Volume: 60, Issue:10

    Topics: Eye Diseases; Fluorocarbons; Humans

2019
Globe rupture and development of surgical emphysema during injection of perfluoro-n-octane (PFO).
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2019, Volume: 54, Issue:2

    Topics: Aged, 80 and over; Emphysema; Eye Diseases; Female; Fluorocarbons; Humans; Injections, Intraocular; Intraoperative Complications; Magnetic Resonance Imaging; Orbital Diseases; Retinal Detachment; Rupture, Spontaneous

2019
The stability of perfluoro-N-octane during vitreoretinal procedures.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Cell Division; Cells, Cultured; Chromatography, Gas; Cryosurgery; Diathermy; Drug Stability; Eye Diseases; Female; Fibroblasts; Fluorocarbons; Humans; Laser Therapy; Magnetic Resonance Spectroscopy; Male; Middle Aged; Rabbits; Retinal Diseases; Spectrophotometry, Ultraviolet; Vitreous Body

1996
The effect of simultaneous internal tamponade on fluid compartmentalization and its relationship to cell proliferation.
    Retina (Philadelphia, Pa.), 1992, Volume: 12, Issue:3 Suppl

    Topics: Adult; Cell Division; Dimethylpolysiloxanes; Eye Diseases; Female; Fluorocarbons; Follow-Up Studies; Fundus Oculi; Humans; Male; Middle Aged; Pigment Epithelium of Eye; Recurrence; Retinal Detachment; Retinal Diseases; Silicone Oils; Silicones; Vitreous Body

1992
Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy.
    Ophthalmology, 1991, Volume: 98, Issue:11

    Topics: Adult; Child; Eye Diseases; Female; Fluorocarbons; Follow-Up Studies; Humans; Male; Middle Aged; Postoperative Complications; Reoperation; Retinal Detachment; Retinal Diseases; Retinal Perforations; Scleral Buckling; Treatment Outcome; Visual Acuity; Vitrectomy; Vitreous Body

1991